Mounjaro price increases have prompted patients to search for cheaper options, including Wegovy. But is it possible to swap partway ...

The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes ...

America’s obesity crisis extends beyond humans — studies suggest that around 60% of dogs and cats nationwide are overweight.

Viking Therapeutics shares plunged 40% after trial data for its obesity pill, VK2735, revealed high dropout rates due to side ...

Beneficiaries using Tricare Prime, Tricare Standard and premium-based plans will continue to have access but must meet specific criteria.

Eli Lilly and Novo Nordisk are expected to price their new obesity pills in line with existing injections, as analysts cite ...

VK2735 met its primary endpoint but failed to outdo competitors Novo Nordisk and Eli Lilly in terms of body weight loss.

Novo Nordisk is slashing the price of its blockbuster diabetes drug Ozempic for U.S. patients who self-pay or are uninsured.

With the price of Mounjaro set to rise, many are hoping for a replacement and a new drug could be out next year ...

Although the FDA has since removed these drugs from its shortage list, stakeholders say compounded drugs continue to be sold.

Ozempic accidentally became a cultural phenomenon. The drug, first delivered to diabetes patients in 2017, had a huge impact ...

Wegovy is now positioned as the first and only GLP-1 treatment.